Aaronson, "Growth Factors and Cancer", Science 254:1146-1153 (1991). |
Adelman et al., "In Vitro Deletional Mutagenesis for Bacterial Production of the 20,000-Dalton Form of Human Pituitary Growth Hormone", DNA 2:183-193 (1983). |
Barbacid et al, "The trk family of tyrosine kinase receptors", Biochimica et Biophysica Acta 1072:115-127 (1991). |
Bargmann et al., "The neu oncogene encodes an epidermal growth factor receptor-related protein", Nature 319:226-230 (1986). |
Bird et al., "Single-Chain Antigen-Binding Proteins", Science 242:423-426 (1988). |
Blaikie et al., "A Region in Shc Distinct from the SH2 Domain Can Bind Tyrosine-phosphorylated Growth Factor Receptors," J. Biol. Chem. 269:32031-32034 (1994). |
Bongarzone et al., "High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma", Oncogene 4:1457-1462 (1989). |
Campbell et al., "Poloyma middle tumor antigen interacts with SHC protein via the NPTY (Asn-Pro-Thr-Tyr) motif in middle tumor antigen," Proc. Natl. Acad. Sci. USA 91:6344-6348 (1994). |
Colbere-Garapin et al., "A New Dominant Hybrid Selective Marker for Higher Eukaryotic Cells", J. Mol. Biol. 150:1-14 (1981). |
Cole et al., "The EBV-Hybridoma Technique and its Application to Human Lung Cancer", pp. 77-96 in Monoclonal Antibodies and Cancer Therapy, eds. Reisfeld and Sell, Alan R. Liss, Inc., New York (1985). |
Coussens et al., "Tyrosine Kinase Receptor with Extensive Homology to EGF Receptor Shares Chromosomal Location with neu Oncogene", Science 230:1132-1139 (1985). |
Creighton, Proteins: Structures and Molecular Principles, pp. 79-86, W.H. Freeman and Co., New York, (1983). |
Davies, "Tracking neurotrophin function", Nature 368:193-194 (1994). |
Dougall et al., "The neu-oncogene: signal transduction pathways, transformation mechanisms and evolving therapies," Oncogene 9:2109-2123 (1994). |
Fingl and Woodbury, Chapter 1, pp.1-46 in The Pharmacological Basis of Therapeutics (5th edition), eds. Goodman et al., MacMillan Publishing Co., Inc., New York (1975). |
Fry et al., "New insights into protein-tyrosine kinase receptor signaling complexes," Protein Science 2:1785-1797 (1993). |
Hardie, D.G., "Roles of Protein Kinases and Phosphatases in Signal Transduction", Symp. Soc. Exp. Bio. 44:241-255 (1990). |
Harris et al., "Breast Cancer (First of Three Parts)", New England J. of Medicine 327:319-328 (1992). |
Hunter, T., "Cooperation between Oncogenes", Cell 64:249-270 (1991). |
Huse et al., "Generation of a Large Combinatorial Library of the Immunoglobulin Repertoire in Phage Lambda", Science 246:1275-1281 (1989). |
Huston et al., "Protein engineering of antibody binding sites: Recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli", Proc. Natl. Acad. Sci. USA 85:5879-5883 (1988). |
Inouye and Inouye, "Up-promotor mutations in the lpp gene of Escherichia coli", Nucleic Acids Research 13:3100-3111 (1985). |
Kaplan et al., "The trk Proto-Oncogene Product: A Signal Transducing Receptor for Nerve Growth Factor", Science 252:554-558 (1991). |
Kavanaugh and Williams, "An Alternative to SH2 Domains for Binding Tyrosine-Phosphorylated Proteins," Science 266:1862-1866 (1994). |
Klein et al., "The trkB Tyrosine Protein Kinase is a Receptor for Brain-Derived Neurotrophic Factor and Neurotrophin-3", Cell 66:395-403 (1991). |
Klein et al., "Disruption of the neurotrophin-3 receptor gene trkC eliminates la muscle afferents and results in abnormal movements", Nature 368:249-251 (1994). |
Koch et al., "SH2 and SH3 Domains: Elements That Control Interactions of Cytoplasmic Signaling Proteins", Science 252:668-674 (1991). |
Kohler and Milstein, "Continuous cultures of fused cells secreting antibody of predefined specificity", Nature 256:495-497 (1975). |
Lam et al., "A new type of synthetic peptide library for identifying ligand-binding activity", Nature 354:82-84 (1991). |
Logan and Shenk, "Adenovirus tripartite leader sequence enhances translation of mRNAs late after infection", Proc. Natl. Acad. Sci. USA 81:3655-3659 (1984). |
Lowy et al., "Isolation of Transforming DNA: Cloning the Hamster aprt Gene", Cell 22:817-823 (1980). |
Marasco et al., "Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gp120 single-chain antibody", Proc. Natl. Acad. Sci. USA 90:7889-7893 (1993). |
Marshall, "Search for a Killer: Focus Shifts form Fat to Hormones", Science 259:618-621 (1993). |
Martin-Zanca et al., "A human oncogene formed by the fusion of truncated tropomyosins and protein tyrosine kinase sequences", Nature 319:743-748 (1986). |
Mayer et al., "A novel viral oncogene with structural similarity to phospholipase C", Nature 332:272-275 (1988). |
Miller, "Human gene therapy comes of age", Nature 357:455-460 (1992). |
Morrison et al., "Chimeric human antibody molecules: Mouse antigen-binding domains with human constant region domains", Proc. Natl. Acad. Sci. USA 81:6851-6855 (1984). |
Mulligan and Berg, "Selection for animal cells that express the Escherichia coli gene coding for xanthine-guanine phosphoribosyltransferase", PNAS 78:2072-2076 (1981). |
Musacchio et al., "The PH domain: a common piece in the structural patchwork of signalling proteins", TIBS 18:343-348 (1993). |
Neuberger et al., "Recombinant antibodies possessing novel effector functions", Nature 312:604-608 (1984). |
O'Hare et al., "Transformation of mouse fibroblasts to methotrexate resistance by a recombinant plasmid expressing a prokaryotic dihydrfolate reductase", PNAS 78:1527-1531 (1981). |
Obermeier et al., "Tyrosine 785 is a major determinate of Trk-substrate interaction", The EMBO Journal 12:933-941 (1993). |
Obermeier et al., "Identification of Trk Binding Sites for SHC and Phosphatidylinositol 3'-Kinase and Formation of a Multimeric Signaling Complex", J. Bio. Chem. 268:22963-22966 (1993). |
Padhy et al., "Identification of a Phosphoprotein Specifically Induced by the Transforming DNA of Rat Neuroblastomas", Cell 28:865-871 (1982). |
Park et al., "Mechanism of met Oncogene Activation", Cell 45:895-904 (1986). |
Pawson and Gish, "SH2 and SH3 Domains: From Structure to Function", Cell 71:359-362 (1992). |
Pawson and Schlessinger, "SH2 and SH3 domains", Current Biology 3(7):434-442 (1993). |
Pendergast et al., "BCR-ABL-Induced Oncogenesis is Mediated by Direct Interaction with the SH2 Domain of the GRB-2 Adaptor Protein," Cell, 75:175-185 (1993). |
Plowman et al., "Heregulin induces tyrosine phosphorylation of HER4/p180.sup.erbB4 ", Nature 366:473-475 (1993). |
Posada and Cooper, "Molecular Signal Integration. Interplay Between Serine, Threonine and Tyrosine Phosphorylation", Mol. Biol. of the Cell 3:583-592 (1992). |
Pulciani et al., "Oncogenes in solid human tumours", Nature 300:539-542 (1982). |
Sadowski et al., A Noncatalytic Domain Conserved among Cytoplasmic Protein-Tyrosine Kinases Modifies the Kinase Function and Transforming Activity of Fujinami Sarcoma Virus P130.sup.gag-fps, Mol. and Cell. Biol. 6:4396-4408 (1986). |
Santerre et al., "Expression of prokaryotic genes for hygromycin B and G418 and G418 resistance as dominant-selection markers in mouse L Cells", Gene 30:147-156 (1984). |
Schechter et al., "The neu oncogene: an erb-B-related gened encoding a 185,000-M.sub.r tumour antigen", Nature 312:513-516 (1984). |
Schlessinger and Ullrich, "Growth Factor Signaling by Receptor Tyrosine Kinases", Neuron 9:383-391 (1992). |
Samanta et al., "Ligand and p185.sup.c-neu density govern interactions and tyrosine kinase activation," Proc. Natl. Acad. Sci. USA 91:1711-1715 (1994). |
Schlessinger, "Signal transduction by allosteric receptor oligomerization", Trends Biochem. Sci. 13:443-447 (1988). |
Slamon et al., "Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HEr-2/neu Oncogene", Science 235:177-185 (1987). |
Slamon et al., "Studies of the HER-2/neu Proto-oncogene in Human Breast and Ovarian Cancer", Science 244:707-712 (1989). |
Sliwkowski et al., "Coexpression of erbB2 and erbB3 Proteins Reconstitutes a High Affinity Receptor for Heregulin", J. Biol. Chem. 269:14661-14665 (1994). |
Smeyne et al., "Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene", Nature 368:246-248 (1994). |
Songyang et al., "SH2 Domains Recognize Specific Phosphopeptide Sequences", Cell 72:767-778 (1993). |
Szybalska and Szybalski, "Genetics of Human Cell Lines, IV. DNA-Mediated Heritable Transformation of a Biochemical Trait", PNAS 48:2026-2034 (1962). |
Takeda et al., "Construction of chimaeric processed immunoglobulin genes containing mouse variable and human constant region sequences", Nature 314:452-454 (1985). |
Ullrich and Schlessinger, "Signal Transduction by Receptors with Tyrosine Kinase Activity", Cell 61:203-212 (1990). |
Van Heeke and Schuster, "Expression of Human Asparagine Synthetase in Escherichia coli", J. Biol. Chem. 264:5503-5509 (1989). |
Wada et al., "Intermolecular Association of the p185.sup.neu Protein and EGF Receptor Modulates EGF Receptor Function," Cell 61:1339-1347 (1990). |
Ward et al., "Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli", Nature 341:544-546 (1989). |
Wigler et al., "Transfer of Purified Herpes Virus Thymidine Kinase Gene to Cultured Mouse Cells", Cell 11:223-232 (1977). |
Wigler et al., "Transformation of mammalian cells with an amplifiable dominant-acting gene", PNAS 77:3567-3570 (1980). |
Yamamoto et al., "Similarity of protein encoded by the human C-erb-B-2 gene to epidermal growth factor receptor", Nature 319:230-234 (1986). |